Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver
- PMID: 22893453
- DOI: 10.1507/endocrj.ej12-0228
Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver
Abstract
Obesity is less common in the Asian population, but Asian people may be susceptible to obesity-associated metabolic dysregulation. Accumulating evidence suggests that insulin resistance is closely associated with ectopic fat accumulation in the liver. Whether this correlation is due to a causal relationship between the conditions has long been the subject of debate. Insulin resistance and type 2 diabetes affects liver pathology, typically leading to nonalcoholic fatty liver disease (NAFLD) by dynamically altering the hepatic genes involved in glucose and lipid metabolism. Conversely, how overnutrition induces hepatic insulin resistance has been studied intensively, and has been shown to involve excessive energy flux into mitochondria, toxic lipids, reactive oxygen species, and hepatokines. In this review, we focus on NAFLD both as a consequence and as a cause of insulin resistance through lessons learned from the liver of patients with type 2 diabetes.
Similar articles
-
Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.Endocr Metab Immune Disord Drug Targets. 2019;19(2):185-188. doi: 10.2174/1871530318666180716100543. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30009716
-
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.Trends Mol Med. 2006 Dec;12(12):555-8. doi: 10.1016/j.molmed.2006.10.001. Epub 2006 Oct 17. Trends Mol Med. 2006. PMID: 17049925
-
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24. Mol Cell Endocrinol. 2015. PMID: 25724480 Review.
-
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.Mol Cell Endocrinol. 2013 Oct 15;379(1-2):35-42. doi: 10.1016/j.mce.2013.06.002. Epub 2013 Jun 12. Mol Cell Endocrinol. 2013. PMID: 23770462 Review.
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8. Gastroenterology. 2012. PMID: 22326434 Review.
Cited by
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489. Int J Mol Sci. 2022. PMID: 36555127 Free PMC article. Review.
-
Plekhs1 and Prdx3 are candidate genes responsible for mild hyperglycemia associated with obesity in a new animal model of F344-fa-nidd6 rat.J Vet Med Sci. 2016 Dec 1;78(11):1683-1691. doi: 10.1292/jvms.16-0383. Epub 2016 Aug 11. J Vet Med Sci. 2016. PMID: 27523322 Free PMC article.
-
Pathophysiological significance of hepatokine overproduction in type 2 diabetes.Diabetol Int. 2018 Aug 17;9(4):224-233. doi: 10.1007/s13340-018-0368-9. eCollection 2018 Oct. Diabetol Int. 2018. PMID: 30603372 Free PMC article.
-
Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway.Acta Pharmacol Sin. 2020 Mar;41(3):383-393. doi: 10.1038/s41401-019-0311-z. Epub 2019 Oct 28. Acta Pharmacol Sin. 2020. PMID: 31659239 Free PMC article.
-
A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.Eur J Nutr. 2016 Feb;55(1):1-6. doi: 10.1007/s00394-015-1073-0. Eur J Nutr. 2016. PMID: 26476631 Review.